ProQR Therapeutics (PRQR) Receivables (2022 - 2025)
ProQR Therapeutics' Receivables history spans 1 years, with the latest figure at $57.8 million for Q4 2022.
- For Q4 2022, Receivables changed N/A year-over-year to $57.8 million; the TTM value through Dec 2022 reached $57.8 million, changed N/A, while the annual FY2022 figure was $59.7 million, N/A changed from the prior year.
- Receivables for Q4 2022 was $57.8 million at ProQR Therapeutics.
- Across five years, Receivables topped out at $57.8 million in Q4 2022 and bottomed at $57.8 million in Q4 2022.